APYXApyx Medical Corpvs its industry peers
A metric-by-metric comparison of Apyx Medical Corp against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APYXThis | $127M#3 | — | 11.9x#3 | 2.4x#2 | 9.9%#1 | 52.2%#1 | -12.2%#2 | -105.1%#3 | -23.6%#1 | 6#1 | — | — |
| OSUR | $241M#1 | — | 0.8x#1 | 2.1x#1 | -38.1%#3 | -252.5%#3 | -62.6%#3 | -21.6%#2 | -43.8%#2 | — | — | — |
| UTMD | $236M#2 | 22.6x#1 | 1.9x#2 | 6.1x#3 | -5.8%#2 | -18.7%#2 | 29.6%#1 | 9.2%#1 | — | — | — | 1.7%#1 |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice